TY - JOUR AU - Vornicova, Olga AU - Bar-Sela, Gil PY - 2019 TI - Do we have a “game changer” in treating patients with brain metastasis from renal cell carcinoma? JF - Annals of Translational Medicine; Vol 7, Supplement 8 (December 31, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Renal cell carcinoma (RCC) is the most common type of kidney cancer. About 25% of patients are diagnosed with metastatic disease at presentation and another 25–30% diagnosed with localized disease will develop metastasis over time (1). The incidence of brain metastasis (BM) ranged from 3–17% in various studies. UR - https://atm.amegroups.org/article/view/29285